LGC and Q2 Solutions announce global bioanalytical strategic partnership

News (ZH) - Will each contribute extensive experience and capabilities in small and large molecule bioanalysis to support customer-centric approach

LGC food forensic expert honoured by Queen’s University

News (ZH) - A leading expert in food safety and authenticity, and a longtime partner of IGFS, Michael Walker has received an honorary professorship from Queen’s University Belfast.

New £1.3 million national research programme to evaluate coronavirus tests in hospitals, GP surgeries and care homes

News (ZH) - Research programme brings together experts who are highly experienced in evaluating diagnostic tests and generating robust evidence required for a test to be used in the NHS

COVID-19 recovery trials: Dexamethasone and standardisation

博客 - Dexamethasone has undergone study by a team of scientists at Oxford University as part of their Recovery trial.

LGC expands SARS-CoV-2 serology offering with 11-member positive-patient Performance Panel

News (ZH) - Panel demonstrates a range of SARS-CoV-2 antibody reactivity

LGC scientists support investigations into unlicensed 'medicines'

博客 - LGC’s Teddington-based Medicines Testing Team supported the MHRA investigation in 2015, testing samples (all of which proved negative) for the presence of vitamin D2.

LGC announces changes to its Executive Leadership Team

News (ZH) - These changes follow recent strong trading performance and further strategy endorsement by Cinven and Astorg, LGC’s new shareholders.

OliX Pharmaceuticals signs agreement with LGC to accelerate production of asymmetric siRNA for the treatment of Sub-Retinal Fibrosis and Wet Macular Degeneration

News (ZH) - LGC will produce active pharmaceutical ingredients for preclinical and clinical study of OLX301D programme

How does standardization protect the environment?

博客 - Through our development of manufacturing and reference materials, studies on standardization, and genomics work, we enable scientists to better understand the impact of human activities.

NML at LGC joins more than 500 scientists in 18 countries to map COVID-19 effects and treatments in patients’ blood

News (ZH) - Aims to refine testing approaches, stratify treatment options, determine isolation requirements and speed up measurement